Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...

Lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without disclosing safety and risk information.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.